Abstract:AbstractMore than 30% of primary prostate cancers contain a consensus deletion of an approximately 800 kb locus on chromosome 6q15.1. The MAP3K7 gene, which encodes TGF-β activated kinase-1 (Tak1), is a putative prostate tumor suppressor gene within this region whose precise function remains obscure. In this study, we investigated the role of Tak1 in human and murine prostate cancers. In 50 well-characterized human cancer specimens, we found that Tak1 expression was progressively lost with increasing Gleason grade, both within each cancer and across all cancers. In murine prostate stem cells and Tak1-deficient prostatic epithelial cells, Tak1 loss increased proliferation, migration, and invasion. When prostate stem cells attenuated for Tak1 were engrafted with fetal urogenital mesenchyme, the histopathology of the grafts reflected the natural history of prostate cancer leading from prostatic intraepithelial neoplasia to invasive carcinoma. In the grafts containing Tak1-suppressed prostate stem cells, p38 and c-jun-NH2-kinase activity was attenuated and proliferation was increased. Together, our findings functionally validate the proposed tumor suppressor role of Tak1 in prostate cancer. Cancer Res; 72(11); 2833–43. ©2012 AACR.

Supplementary Table 1 from Suppression of Tak1 Promotes Prostate Tumorigenesis

Supplementary Figure 1 from Suppression of Tak1 Promotes Prostate Tumorigenesis

Supplementary Figure 3 from Suppression of Tak1 Promotes Prostate Tumorigenesis

Supplementary Table 2 from Suppression of Tak1 Promotes Prostate Tumorigenesis

Supplementary Figure 2 from Suppression of Tak1 Promotes Prostate Tumorigenesis

Data from Suppression of Tak1 Promotes Prostate Tumorigenesis

Supplementary Figure 4 from Suppression of Tak1 Promotes Prostate Tumorigenesis

Supplementary Figures 1-2, Tables 1-8 from Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis

Supplementary Table 1 from Interleukin-17 Promotes Formation and Growth of Prostate Adenocarcinoma in Mouse Models

Supplementary Table 1 from MicroRNA-616 Induces Androgen-Independent Growth of Prostate Cancer Cells by Suppressing Expression of Tissue Factor Pathway Inhibitor TFPI-2

Supplementary Tables from Infiltrating Macrophages Promote Prostate Tumorigenesis Via Modulating Androgen Receptor-Mediated CCL4–STAT3 Signaling

Supplementary Figures 1-3, Tables 1-3, Table 7, Legends for Figures 1-3, Tables 1-7 from B-Raf Activation Cooperates with PTEN Loss to Drive C-Myc Expression in Advanced Prostate Cancer

Supplemental Table 1 from RB Loss Promotes Prostate Cancer Metastasis

Supplementary Table S1 from the Tumor-Suppressive Function of UNC5D and Its Repressed Expression in Renal Cell Carcinoma

Supplementary Figure 4 from FGFR1 is Essential for Prostate Cancer Progression and Metastasis

Supplementary Table S1 from YAP1 Inhibition Induces Phenotype Switching of Cancer-Associated Fibroblasts to Tumor Suppressive in Prostate Cancer

Supplementary Figures 1-7 from <i>Pten</i> Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells

Supplementary Table 1 from Novel Oncogene–Induced Metastatic Prostate Cancer Cell Lines Define Human Prostate Cancer Progression Signatures

Supplementary Table 2 from CBP Loss Cooperates with PTEN Haploinsufficiency to Drive Prostate Cancer: Implications for Epigenetic Therapy

Supplementary Figures 1-4 from Lin<sup>−</sup>Sca-1<sup>+</sup>CD49f<sup>high</sup> Stem/Progenitors Are Tumor-Initiating Cells in the <i>Pten</i>-Null Prostate Cancer Model

Supplemental Table 2 from PADI2-Mediated Citrullination Promotes Prostate Cancer Progression